Skip to main content

Table 1 Testing result of 5 cases infantile hemangiomas specimens, growth inhibition rates (%)

From: Application of the adenosine triphosphate sensitivity assay in infantile vascular anomalies

Testing drug400%200%100%50%25%12.5%TGI
Patient No.1
 Propranolol18.048.839.955.343.811.1647.13
 Rapamycin19.0244.8719.1025.2116.7524.26149.21
 Sildenafil2.13−9.31−14.08−19.25−38.13−46.28− 124.92
 Itraconazole49.7758.4318.98−22.858.5617.01129.9
Patient No.2
 Propranolol27.9918.0322.0518.6318.5920.94126.23
 Rapamycin27.0614.245.915.2887.1910.31149.99
 Sildenafil15.02−29.00−13.13−23.39−12.60−8.77−71.87
 Itraconazole12.0645.7953.0425.30−8.0153.94182.12
Patient No.3
 Propranolol23.0623.2727.940.8611.5532.94119.62
 Rapamycin42.9944.0235.6138.3739.4632.60233.05
 Sildenafil−11.26−1.60−13.39− 10.91−1.42− 15.48− 54.06
 Itraconazole32.0223.1213.062.13−8.28−10.3151.74
Patient No.4
 Propranolol32.7613.5440.2136.6642.3731.43196.97
 Rapamycin13.0356.738.1550.8145.7211.57186.01
 Sildenafil−6.9016.4518.6126.6915.26−7.2762.84
Patient No.5
 Propranolol4.296.240.5011.708.3113.5344.57
 Rapamycin42.8456.0152.1248.7447.4537.93285.09
 Sildenafil12.368.49−7.875.00−7.87−7.902.21
  1. TGI total growth inhibition rate, summation of the percentage of growth inhibition at every testing concentration
\